AOCNP EXAM PRACTICE QUESTIONS &
RATIONALES LATEST 2025-2026 UPDATED
BLUEPRINT TEST BANK (GRADED A+)
Master your certification with this premium, question
AOCNP practice exam study bank updated to align with the
latest 2025/2026 oncology blueprint and NCCN clinical
guidelines. Every high-yield multiple-choice question
features the correct answer immediately followed by an
italicized explanation and a bolded, comprehensive clinical
rationale for rapid learning. Perfect for nurse practitioners
seeking a proven, structured test-prep tool to guarantee an
A+ score and pass the board exam on the first try.
Question 1
A 55-year-old female patient with metastatic breast cancer is
receiving chemotherapy and presents with sudden onset of dyspnea,
tachycardia, and a cough. Her D-dimer is elevated, and a CT
pulmonary angiogram confirms a pulmonary embolism (PE).
According to current clinical guidelines, which is the preferred initial
long-term anticoagulation therapy for this cancer-associated
thrombosis?
A) Unfractionated heparin
B) Warfarin
C) Low-molecular-weight heparin (LMWH) or a direct oral
anticoagulant (DOAC) like apixaban
D) Aspirin 325 mg daily
Correct Answer: C) Low-molecular-weight heparin (LMWH) or a
direct oral anticoagulant (DOAC) like apixaban
,Rationale: Current international guidelines (such as ASCO and
NCCN) recommend LMWH or specific DOACs (like apixaban or
rivaroxaban) over warfarin for the treatment of cancer-associated
thrombosis due to superior efficacy and a lower recurrence rate,
provided there are no significant gastrointestinal bleeding risks.
Question 2
Which of the following oncologic emergencies is characterized by
the rapid lysis of malignant cells, leading to hyperkalemia,
hyperuricemia, hyperphosphatemia, and hypocalcemia?
A) Superior Vena Cava Syndrome
B) Tumor Lysis Syndrome (TLS)
C) Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
D) Spinal Cord Compression
Correct Answer: B) Tumor Lysis Syndrome (TLS)
Rationale: Tumor Lysis Syndrome occurs when a large number of
cancer cells die rapidly, spilling their intracellular contents into the
bloodstream. This leads to the classic metabolic triad of
hyperkalemia, hyperuricemia, and hyperphosphatemia, with
secondary hypocalcemia due to calcium phosphate precipitation.
Question 3
A patient with non-small cell lung cancer (NSCLC) tests positive for
an EGFR exon 19 deletion. Which of the following targeted therapies
is considered a first-line treatment option for this patient?
A) Osimertinib
B) Crizotinib
C) Trastuzumab
D) Bevacizumab
Correct Answer: A) Osimertinib
Rationale: Osimertinib is a third-generation EGFR tyrosine kinase
inhibitor (TKI) indicated as first-line treatment for patients with
metastatic NSCLC whose tumors have EGFR exon 19 deletions or
exon 21 L858R mutations.
,Question 4
During a routine follow-up, a patient with multiple myeloma reports
new, progressive lower back pain that worsens when lying flat,
accompanied by bilateral lower extremity weakness. What is the
most appropriate immediate next step?
A) Order physical therapy for lower back strengthening
B) Increase the dose of immediate-release opioids
C) Obtain an urgent spine MRI to evaluate for spinal cord
compression
D) Schedule a routine bone density scan
Correct Answer: C) Obtain an urgent spine MRI to evaluate for spinal
cord compression
Rationale: New-onset back pain that worsens when supine,
combined with neurological deficits like weakness, strongly
suggests neoplastic spinal cord compression. This is a medical
emergency requiring immediate imaging (MRI) and prompt
intervention with steroids and radiation or surgery to prevent
permanent paralysis.
Question 5
Which class of chemotherapeutic agents is most notoriously
associated with a dose-dependent, cumulative risk of cardiotoxicity
and cardiomyopathy?
A) Taxanes
B) Anthracyclines
C) Platinum agents
D) Antimetabolites
Correct Answer: B) Anthracyclines
Rationale: Anthracyclines (such as doxorubicin and daunorubicin)
carry a well-documented risk of cumulative, irreversible type I
cardiotoxicity. Lifetime cumulative doses must be monitored closely
to reduce the risk of congestive heart failure.
Question 6
, A melanoma patient receiving treatment with the immune checkpoint
inhibitor pembrolizumab presents with a new onset of severe
diarrhea (5–6 loose stools above baseline) and abdominal cramping.
After ruling out infectious etiologies, which intervention is indicated
first?
A) Administer loperamide and continue pembrolizumab
B) Hold pembrolizumab and initiate systemic corticosteroids (e.g.,
prednisone 1–2 mg/kg/day)
C) Permanently discontinue pembrolizumab and start permanent
TPN
D) Administer a dose of infliximab immediately
Correct Answer: B) Hold pembrolizumab and initiate systemic
corticosteroids (e.g., prednisone 1–2 mg/kg/day)
Rationale: Severe diarrhea/colitis induced by immune checkpoint
inhibitors represents an immune-related adverse event (irAE). Grade
2 or 3 colitis requires holding the immunotherapy and starting
systemic corticosteroids to suppress the overactive immune
response.
Question 7
What is the primary mechanism of action of the monoclonal antibody
rituximab?
A) Binds to VEGFR to inhibit angiogenesis
B) Targets the CD20 antigen on B lymphocytes, leading to cell lysis
C) Inhibits the HER2/neu receptor tyrosine kinase
D) Blocks the PD-1 receptor on T cells
Correct Answer: B) Targets the CD20 antigen on B lymphocytes,
leading to cell lysis
Rationale: Rituximab is a chimeric monoclonal antibody that
specifically targets the CD20 antigen found on the surface of normal
and malignant B lymphocytes, inducing apoptosis, complement-
dependent cytotoxicity, and antibody-dependent cellular
cytotoxicity.
RATIONALES LATEST 2025-2026 UPDATED
BLUEPRINT TEST BANK (GRADED A+)
Master your certification with this premium, question
AOCNP practice exam study bank updated to align with the
latest 2025/2026 oncology blueprint and NCCN clinical
guidelines. Every high-yield multiple-choice question
features the correct answer immediately followed by an
italicized explanation and a bolded, comprehensive clinical
rationale for rapid learning. Perfect for nurse practitioners
seeking a proven, structured test-prep tool to guarantee an
A+ score and pass the board exam on the first try.
Question 1
A 55-year-old female patient with metastatic breast cancer is
receiving chemotherapy and presents with sudden onset of dyspnea,
tachycardia, and a cough. Her D-dimer is elevated, and a CT
pulmonary angiogram confirms a pulmonary embolism (PE).
According to current clinical guidelines, which is the preferred initial
long-term anticoagulation therapy for this cancer-associated
thrombosis?
A) Unfractionated heparin
B) Warfarin
C) Low-molecular-weight heparin (LMWH) or a direct oral
anticoagulant (DOAC) like apixaban
D) Aspirin 325 mg daily
Correct Answer: C) Low-molecular-weight heparin (LMWH) or a
direct oral anticoagulant (DOAC) like apixaban
,Rationale: Current international guidelines (such as ASCO and
NCCN) recommend LMWH or specific DOACs (like apixaban or
rivaroxaban) over warfarin for the treatment of cancer-associated
thrombosis due to superior efficacy and a lower recurrence rate,
provided there are no significant gastrointestinal bleeding risks.
Question 2
Which of the following oncologic emergencies is characterized by
the rapid lysis of malignant cells, leading to hyperkalemia,
hyperuricemia, hyperphosphatemia, and hypocalcemia?
A) Superior Vena Cava Syndrome
B) Tumor Lysis Syndrome (TLS)
C) Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
D) Spinal Cord Compression
Correct Answer: B) Tumor Lysis Syndrome (TLS)
Rationale: Tumor Lysis Syndrome occurs when a large number of
cancer cells die rapidly, spilling their intracellular contents into the
bloodstream. This leads to the classic metabolic triad of
hyperkalemia, hyperuricemia, and hyperphosphatemia, with
secondary hypocalcemia due to calcium phosphate precipitation.
Question 3
A patient with non-small cell lung cancer (NSCLC) tests positive for
an EGFR exon 19 deletion. Which of the following targeted therapies
is considered a first-line treatment option for this patient?
A) Osimertinib
B) Crizotinib
C) Trastuzumab
D) Bevacizumab
Correct Answer: A) Osimertinib
Rationale: Osimertinib is a third-generation EGFR tyrosine kinase
inhibitor (TKI) indicated as first-line treatment for patients with
metastatic NSCLC whose tumors have EGFR exon 19 deletions or
exon 21 L858R mutations.
,Question 4
During a routine follow-up, a patient with multiple myeloma reports
new, progressive lower back pain that worsens when lying flat,
accompanied by bilateral lower extremity weakness. What is the
most appropriate immediate next step?
A) Order physical therapy for lower back strengthening
B) Increase the dose of immediate-release opioids
C) Obtain an urgent spine MRI to evaluate for spinal cord
compression
D) Schedule a routine bone density scan
Correct Answer: C) Obtain an urgent spine MRI to evaluate for spinal
cord compression
Rationale: New-onset back pain that worsens when supine,
combined with neurological deficits like weakness, strongly
suggests neoplastic spinal cord compression. This is a medical
emergency requiring immediate imaging (MRI) and prompt
intervention with steroids and radiation or surgery to prevent
permanent paralysis.
Question 5
Which class of chemotherapeutic agents is most notoriously
associated with a dose-dependent, cumulative risk of cardiotoxicity
and cardiomyopathy?
A) Taxanes
B) Anthracyclines
C) Platinum agents
D) Antimetabolites
Correct Answer: B) Anthracyclines
Rationale: Anthracyclines (such as doxorubicin and daunorubicin)
carry a well-documented risk of cumulative, irreversible type I
cardiotoxicity. Lifetime cumulative doses must be monitored closely
to reduce the risk of congestive heart failure.
Question 6
, A melanoma patient receiving treatment with the immune checkpoint
inhibitor pembrolizumab presents with a new onset of severe
diarrhea (5–6 loose stools above baseline) and abdominal cramping.
After ruling out infectious etiologies, which intervention is indicated
first?
A) Administer loperamide and continue pembrolizumab
B) Hold pembrolizumab and initiate systemic corticosteroids (e.g.,
prednisone 1–2 mg/kg/day)
C) Permanently discontinue pembrolizumab and start permanent
TPN
D) Administer a dose of infliximab immediately
Correct Answer: B) Hold pembrolizumab and initiate systemic
corticosteroids (e.g., prednisone 1–2 mg/kg/day)
Rationale: Severe diarrhea/colitis induced by immune checkpoint
inhibitors represents an immune-related adverse event (irAE). Grade
2 or 3 colitis requires holding the immunotherapy and starting
systemic corticosteroids to suppress the overactive immune
response.
Question 7
What is the primary mechanism of action of the monoclonal antibody
rituximab?
A) Binds to VEGFR to inhibit angiogenesis
B) Targets the CD20 antigen on B lymphocytes, leading to cell lysis
C) Inhibits the HER2/neu receptor tyrosine kinase
D) Blocks the PD-1 receptor on T cells
Correct Answer: B) Targets the CD20 antigen on B lymphocytes,
leading to cell lysis
Rationale: Rituximab is a chimeric monoclonal antibody that
specifically targets the CD20 antigen found on the surface of normal
and malignant B lymphocytes, inducing apoptosis, complement-
dependent cytotoxicity, and antibody-dependent cellular
cytotoxicity.
